EUVIMEDEUVIMED entdecken
Crossref

Long‐Term Clinical Effectiveness of and Adherence to Onabotulinumtoxin A Injections for Neurogenic Detrusor Overactivity

Julia Neuenschwander iD, Jürgen Pannek iD, Jens Wöllner iD, Jörg Krebs iD

Neurourology and Urodynamics · 07.10.2026

DOI: 10.1002/nau.70469 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurourology and Urodynamics, online erschienen am 07.10.2026. Verfasst von Julia Neuenschwander und 3 weiteren Autor:innen. Beteiligte Einrichtung: Neuro-Urology, Swiss Paraplegic Centre, Nottwil, Switzerland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study Design Retrospective cohort study in consecutive patients.

Objective

To evaluate the long‐term effectiveness of and treatment adherence to intradetrusor onabotulinumtoxin A (BoNT‐ONA) injections in patients with neurogenic detrusor overactivity (NDO).

Methods

Consecutive patients with NDO who had undergone intradetrusor BoNT‐ONA treatment at a single tertiary neuro‐urology referral center were identified from a registry documenting off‐label use of BoNT‐ONA prior to formal regulatory approval. Demographic, clinical, and urodynamic data obtained before and after each treatment were collected. In patients performing intermittent catheterization, treatment success was defined by the following urodynamic criteria: bladder capacity ≥ 400 mL, bladder compliance ≥20 mL/cmH 2 O, and maximum detrusor storage pressure

Schlagwörter

Stichwörter der Autor:innen

neurogenic detrusor overactivityneurogenic lower urinary tract dysfunctiononabotulinumtoxin Aspinal cord injury

Autor:innen und Institutionen

  • Neuro-Urology, Swiss Paraplegic Centre, Nottwil, Switzerland.
  • Neuro-Urology, Swiss Paraplegic Research, Nottwil, Switzerland.
  • Department of Urology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Medicine and Medical Sciences, Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.

ORCID-Profile: Julia Neuenschwander, Jürgen Pannek, Jens Wöllner, Jörg Krebs

Zitieren

APA

Neuenschwander, J., Pannek, J., Wöllner, J., & Krebs, J. (2026). Long‐Term Clinical Effectiveness of and Adherence to Onabotulinumtoxin A Injections for Neurogenic Detrusor Overactivity. Neurourology and Urodynamics. https://doi.org/10.1002/nau.70469

Vancouver

Neuenschwander J, Pannek J, Wöllner J, Krebs J. Long‐Term Clinical Effectiveness of and Adherence to Onabotulinumtoxin A Injections for Neurogenic Detrusor Overactivity. Neurourology and Urodynamics. 2026. doi:10.1002/nau.70469

BibTeX
@article{Neuenschwander2026,
  author = {Neuenschwander, Julia and Pannek, Jürgen and Wöllner, Jens and Krebs, Jörg},
  title = {Long‐Term Clinical Effectiveness of and Adherence to Onabotulinumtoxin A Injections for Neurogenic Detrusor Overactivity},
  journal = {Neurourology and Urodynamics},
  year = {2026},
  doi = {10.1002/nau.70469}
}
Kostenlos starten →